Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSLLY | AMGN | BMY | GILD | MRNA |
| Company | Csl Ltd ADR | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 88.2880 | 266.83 | 48.45 | 67.80 | 102.08 |
| High | 88.2880 | 267.51 | 48.59 | 67.89 | 106.42 |
| Low | 87.3000 | 263.81 | 48.24 | 67.19 | 101.30 |
| Last | 87.5750 | 265.06 | 48.38 | 67.44 | 104.86 |
| Change | -1.9250 | -0.45 | -0.13 | -0.31 | +1.00 |
| % Change | -2.15% | -0.17% | -0.27% | -0.46% | +0.96% |
| Volume | 25,602 | 914,959 | 5,613,239 | 2,245,563 | 1,302,590 |
| 20-Day Average Volume | 29,540 | 2,209,808 | 11,192,188 | 6,281,165 | 3,330,238 |
| Previous Close | 89.5000 | 265.51 | 48.51 | 67.75 | 103.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 92.0171 | 273.83 | 51.37 | 70.94 | 105.64 |
| 20-Day Raw Stochastic | 3.22% | 3.78% | 4.80% | 4.21% | 41.40% |
| 20-Day Relative Strength | 33.86% | 38.21% | 36.63% | 31.02% | 51.92% |
| Weighted Alpha | -11.42 | +5.43 | -29.91 | -23.18 | -16.66 |
| Today's Opinion | 40% Sell | 40% Sell | 56% Sell | 100% Sell | 72% Buy |
| Previous Opinion | 8% Buy | 40% Sell | 56% Sell | 100% Sell | 72% Buy |
| Last Month's Opinion | 40% Buy | 8% Sell | 8% Sell | 72% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.74% since 04/09/24 | -2.03% since 04/09/24 | -6.15% since 04/09/24 | -3.52% since 04/09/24 | -6.08% since 04/09/24 |
| Low | 87.3000 on 04/16/24 | 263.95 on 04/16/24 | 48.12 on 04/15/24 | 67.18 on 04/16/24 | 101.46 on 04/16/24 |
| High | 94.3300 on 04/10/24 | 273.00 on 04/11/24 | 51.28 on 04/10/24 | 69.76 on 04/10/24 | 110.29 on 04/10/24 |
| 1-Month | |||||
| %Chg | -4.34% since 03/15/24 | -1.48% since 03/15/24 | -7.48% since 03/15/24 | -8.43% since 03/15/24 | +0.93% since 03/15/24 |
| Low | 87.3000 on 04/16/24 | 263.95 on 04/16/24 | 48.12 on 04/15/24 | 67.18 on 04/16/24 | 97.00 on 04/03/24 |
| High | 95.8300 on 03/28/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 74.28 on 03/21/24 | 115.89 on 04/09/24 |
| 3-Month | |||||
| %Chg | -6.49% since 01/16/24 | -12.72% since 01/16/24 | -3.15% since 01/16/24 | -21.53% since 01/16/24 | +2.60% since 01/16/24 |
| Low | 87.3000 on 04/16/24 | 263.95 on 04/16/24 | 47.58 on 02/06/24 | 67.18 on 04/16/24 | 84.06 on 02/13/24 |
| High | 99.5400 on 01/31/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 115.89 on 04/09/24 |
| 6-Month | |||||
| %Chg | +14.93% since 10/16/23 | -7.67% since 10/16/23 | -15.30% since 10/16/23 | -14.80% since 10/16/23 | +14.01% since 10/16/23 |
| Low | 71.5100 on 10/30/23 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 67.18 on 04/16/24 | 62.55 on 11/02/23 |
| High | 99.9500 on 12/27/23 | 329.72 on 02/05/24 | 57.65 on 10/17/23 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 86,502,200 | 142,291,856 | 98,318,080 | 84,353,968 | 39,765,916 |
| Shares Outstanding, K | 966,505 | 535,919 | 2,026,759 | 1,245,077 | 382,880 |
| Annual Sales | 13,310,000,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | 2,194,000,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | N/A | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,811,000,000 |
| Last Quarter Net Income | N/A | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 217,000,000 |
| 60-Month Beta | 0.73 | 0.58 | 0.39 | 0.19 | 1.62 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 0.55 on 02/22/24 |
| Latest Earnings Date | 09/27/23 | 05/02/24 | 04/25/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | 0.545 on 03/11/24 | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | 03/11/24 | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.33 | 6.44 | 10.13 | 0.00 |